• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis Rep . COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles

tetano

Editor, Senior Moderator
Infect Dis Rep


. 2022 Jun 17;14(3):492-500.
doi: 10.3390/idr14030052.
COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles


Alberto Corriero[SUP] 1 [/SUP], Mario Ribezzi[SUP] 2 [/SUP], Federica Mele[SUP] 3 [/SUP], Carmelinda Angrisani[SUP] 3 [/SUP], Fabio Romaniello[SUP] 4 [/SUP], Antonio Daleno[SUP] 5 [/SUP], Daniela Loconsole[SUP] 6 [/SUP], Francesca Centrone[SUP] 6 [/SUP], Maria Chironna[SUP] 6 [/SUP], Nicola Brienza[SUP] 2 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease is a pandemic that has disrupted many human lives, threatening people's physical and mental health. Each pandemic wave struck in different ways, infectiveness-wise and mortality-wise. This investigation focuses on critically ill patients affected by the last two variants, Delta and Omicron, and aims to analyse if any difference exists between the two groups.
Methods: intensive care unit (ICU) COVID-19 consecutive admissions between 1 October 2021 and 31 March 2022 were recorded daily, and data concerning the patients' demographics, variants, main comorbidities, ICU parameters on admission, and the outcome were analysed by a univariate procedure and by a multivariate analysis.
Results: 65 patients were enrolled, 31 (47.69%) belonging to the Omicron versus 34 (52.31%) to the Delta group. The mortality rate was 52.94% for the Omicron group versus 41.9% for the Delta group. A univariate analysis showed that the Omicron variant was associated with total comorbidities number, Charlson Comorbidity Index (CCI), pre-existing pulmonary disease, vaccination status, and acute kidney injury (AKI). In stepwise multivariate analysis, the total number of comorbidities was positively associated with the Omicron group, while pulmonary embolism was negatively correlated with the Omicron group.
Conclusion: Omicron appears to have lost some of the hallmarks of the Delta variant, such as endothelialitis and more limited cellular tropism when it comes to the patients in the ICU. Further studies are encouraged to explore different therapeutic approaches to treat critical patients with COVID-19.

Keywords: COVID-19; COVID-19 variants; ICU; SARS-CoV-1; SARS-CoV-2; delta; disease severity; endothelial dysfunction; omicron.
 
Back
Top Bottom